Publication:
Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology)

Simple item page
dc.contributor.authorInal, Ali
dc.contributor.authorKodaz, Hilmi
dc.contributor.authorOdabas, Hatice
dc.contributor.authorDuran, Ayse Ocak
dc.contributor.authorSeker, Mehmet Metin
dc.contributor.authorInanc, Mevlide
dc.contributor.authorELKIRAN, EMİN TAMER
dc.contributor.authorGunaydin, Yusuf
dc.contributor.authorMenekse, Serkan
dc.contributor.authorTopcu, Turkan Ozturk
dc.contributor.authorUrakci, Zuhat
dc.contributor.authorTastekin, Didem
dc.contributor.authorBİLİCİ, Mehmet
dc.contributor.authorCihan, Sener
dc.contributor.authorGeredeli, Caglayan
dc.contributor.authorSEZER, EMEL
dc.contributor.authorUncu, Dogan
dc.contributor.authorArpaci, Erkan
dc.contributor.authorOzturk, Banu
dc.contributor.authorBal, Oznur
dc.contributor.authorUYSAL, MÜKREMİN
dc.contributor.authorTANRIVERDİ, ÖZGÜR
dc.contributor.authorGumus, Mahmut
dc.contributor.authorUstaalioglu, Bala Basak Oven
dc.contributor.authorSuner, Ali
dc.contributor.authorCokmert, Suna
dc.contributor.authorHacibekiroglu, Ilhan
dc.contributor.authorAydin, Kubra
dc.contributor.authorIsikdogan, Abdurrahman
dc.date.accessioned2020-10-22T15:59:52Z
dc.date.available2020-10-22T15:59:52Z
dc.date.issued2018-04-01T00:00:00Z
dc.description.abstractPurpose: Almost half of all patients diagnosed with non-small cell lung cancer (NSCLC) have distant metastases at presentation. One-third of patients with NSCLC will have brain metastases. Without effective treatment, the median survival is only 1 month. However, it is difficult to treat brain metastases with systemic chemotherapy since the agents have difficulty crossing the blood-brain barrier. Therefore, it is important to estimate the patient-s survival prognosis. The aim of this study was to analyze prognostic factors for survival in Turkish patients who received chemotherapy after cranial irradiation for NSCLC with brain metastases.
dc.identifier.citationInal A., Kodaz H., Odabas H., Duran A. O. , Seker M. M. , Inanc M., ELKIRAN E. T. , Gunaydin Y., Menekse S., Topcu T. O. , et al., -Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology)-, JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, cilt.14, ss.578-582, 2018
dc.identifier.doi10.4103/0973-1482.176417
dc.identifier.pubmed29893321
dc.identifier.scopus85048665590
dc.identifier.urihttp://hdl.handle.net/20.500.12645/23811
dc.identifier.wosWOS:000435353000019
dc.titlePrognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology)
dc.typeArticle
dspace.entity.typePublication
local.avesis.id60b401f8-7f6c-49fe-9a2c-4a5b389b93b9
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
JCanResTher143578-5057299_140252.pdf
Size:
824.37 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Yayınlar - Eserler